+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Alternative transport pathways of cholephilic 14C-hexobarbital metabolites in rats with experimental hepatitis and cholestasis

Alternative transport pathways of cholephilic 14C-hexobarbital metabolites in rats with experimental hepatitis and cholestasis

Acta Hepato-Gastroenterologica 26(6): 429-434

Object of the investigation was to find out whether otherwise cholephilic metabolites are excreted via an alternative pathway into urine in experimental liver disease. Intraduodenal application of 14C-labelled hexobarbital in rats is followed by an immediate biliary excretion of metabolites in the range of 400 microgram/100 g bw/h. Using TLC these metabolites can be separated into a polar fraction (about 80% of total) and a non-polar fraction. Phenobarbital treatment leads to a decrease of the total biliary excretion of metabolites to about 200 microgram/100 g bw/h, the metabolite pattern remaining unchanged. Animals with a mild form of GalN-hepatitis had a moderate reduction of bile flow and a total metabolite output of 40 microgram/100/gbw/h. The metabolite pattern showed a decrease mainly of the polar fraction. In animals with an early stage of ANIT cholestasis a 50% reduction of bile flow was associated with a total metabolite excretion of only 20 microgram/100 g bw/h and polar metabolites were nearly absent. In both types of experimental liver disease in corresponding urine samples otherwise cholephilic metabolites appeared. The results obtained show that clinically moderate stages of experimental liver disease lead to a significantly diminished output especially of polar 14C-hexobarbital-metabolites into the bile, which can, therefore, appear in the urine instead.

(PDF emailed within 1 workday: $29.90)

Accession: 039224697

Download citation: RISBibTeXText

PMID: 549423

Related references

Alternative transport pathways of cholephilic carbon 14 labeled hexo barbital metabolites in rats with experimental hepatitis and cholestasis. Acta Hepato-Gastroenterologica 26(6): 429-434, 1979

Symposion B: Experimental cholestasis--in vitro metabolism and in vivo metabolic clearance of hexobarbital in rats with ANIT-cholestasis. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 1: 269-271, 1976

Glucuronide conjugation as an alternative bio transformation pathway of hexo barbital and methohexital in rats with experimental hepatitis and cholestasis. Gastroenterologie Clinique et Biologique 6(10): 825, 1982

Biliary transport of cholephilic dyes: evidence for two different pathways. American Journal of Physiology 232(5): E445-E450, 1977

Biliary transport of cholephilic dyes evidence for 2 different pathways. American Journal of Physiology 232(5): NO PAGE, 1977

Differing intrahepatic transport pathways exist for bile acids and cholephilic organic anions. Gastroenterology 98(5 PART 2): A242, 1990

Hexobarbital-oxidation in vivo and in vitro in rats with bile duct ligation or ANIT-cholestasis. Zeitschrift für Gastroenterologie 15(6): 378-380, 1977

Cholephilic dye metabolism in cholestasis. Gastroenterologia Japonica 12(4): 337-338, 1977

Ethynylestradiol ee induced cholestasis in normal and transport mutant rats evidence for separate hepatobiliary excretory pathways for bile acids and bilirubin. Journal of Hepatology 7(SUPPL 1): S42, 1988

Effect of cholestyramine-induced bile acid depletion on the hepatobiliary transport of cholephilic organic anions in rats. Archives Internationales de Pharmacodynamie et de Therapie 245(2): 311-322, 1980

Biliary excretion of cholephilic compounds in ethinylestradiol -induced cholestasis. Gastroenterology 110(4 SUPPL ): A1340, 1996

Does paracellular permeability play a role in cholephilic dye-induced cholestasis?. Toxicology Letters (shannon). 84(1): 13-22, 1996

Biliary excretion of cholephilic compounds in phalloidin-induced rat cholestasis. Hepatology 30(4 PART 2): 333A, 1999

Selected ion monitoring analysis of pseudoracemic hexobarbital and its major metabolites in blood and urine of rats. Biomedical Mass Spectrometry 12(9): 464-469, 1985